Please try another search
For the three months ended 31 March 2020, Shandong Longlive Bio Technology Co Ltd revenues decreased 51% to RMB50.4M. Net loss increased 1% to RMB97.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest Expense increase of 10% to RMB73.5M (expense), Research & Development Expense increase of 52% to RMB6.1M (expense).
Period Ending: | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Total Revenue | 50.41 | 8.71 | 106.15 | 204.63 |
Gross Profit | 9.77 | -8.71 | 16.34 | 35.54 |
Operating Income | -98.63 | -477.97 | -98.97 | -225.04 |
Net Income | -97.73 | -490.9 | -98.08 | -223.09 |
Period Ending: | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Total Assets | 1108.26 | 1125.29 | 1302.09 | 1382.65 |
Total Liabilities | 5254.75 | 5173.72 | 4851.22 | 4844.72 |
Total Equity | -4146.49 | -4048.43 | -3549.13 | -3462.08 |
Period Ending: | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 9.62 | 79.7 | 19.29 | 30.94 |
Cash From Investing Activities | -5.34 | -21.89 | -2.95 | -0.56 |
Cash From Financing Activities | -1.09 | -67.87 | -31.24 | -21.09 |
Net Change in Cash | 3.32 | -9.67 | -14.9 | 9.3 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review